DNAVSECCV• 28 Days (Normalized)
DNA vs ECCV (Ginkgo Bioworks Holdings Inc. vs Eagle Point Credit Company 5.375% Notes due 2029)
Showing Closing Date Range from Sep 11 to Oct 9, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
DNA Performance $13
+92.59%
Ginkgo Bioworks Holdings Inc.
Normalized Baseline0.00%
ECCV Performance $24.04
+0.52%
Eagle Point Credit Company 5.375% Notes due 2029
Normalized Baseline0.00%
Alpha Spread Margin DNA LEADS
+92.07 pts
DNA outperforming by 92.07 percentage points
DNAECCV
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
DNA ECCV
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(21 dates)
| Date | DNA Price | DNA Gain (%) | ECCV Price | ECCV Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 09, 2026 | $13.00 | +92.59% | $24.04 | +0.52% | +92.07% |
| Oct 08, 2026 | $11.34 | +68.00% | $23.95 | +0.15% | +67.85% |
| Oct 07, 2026 | $11.47 | +69.93% | $23.88 | -0.15% | +70.08% |
| Oct 06, 2026 | $12.41 | +83.85% | $23.87 | -0.19% | +84.04% |
| Oct 05, 2026 | $14.98 | +121.93% | $24.07 | +0.63% | +121.30% |
| Oct 02, 2026 | $12.35 | +82.96% | $24.13 | +0.88% | +82.08% |
| Oct 01, 2026 | $12.50 | +85.19% | $24.00 | +0.36% | +84.83% |
| Sep 30, 2026 | $12.83 | +90.07% | $23.92 | +0.00% | +90.07% |
| Sep 29, 2026 | $11.96 | +77.19% | $- | - | |
| Sep 28, 2026 | $10.46 | +54.96% | $- | - | |
| Sep 25, 2026 | $10.66 | +57.93% | $- | - | |
| Sep 24, 2026 | $10.25 | +51.85% | $- | - | |
| Sep 23, 2026 | $8.58 | +27.11% | $- | - | |
| Sep 22, 2026 | $9.37 | +38.81% | $- | - | |
| Sep 21, 2026 | $7.98 | +18.22% | $- | - |
Page 1 of 2